heart-failure

Documents about heart-failure

• Metformin for Pulmonary Hypertension HFpEF#18534ClinicalTrials.gov
• Effects of Viagra on Heart Function in Patients With Heart Failure#18734ClinicalTrials.gov
• Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF)#67711ClinicalTrials.gov
• Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure#67810ClinicalTrials.gov
• Management of Diabetes With Metformin In Patients With Chronic Heart Failure#67812ClinicalTrials.gov
• Rural Hospital-Level Care at Home for Acutely Ill Adults#121415ClinicalTrials.gov
• Role of Cytosorb in Left Ventricular Assist Device Implantation#121519ClinicalTrials.gov
• Correlation and Prognostic Value of Body Composition, Cardiac Structure and Function in Patients With Different Heart Failure Subtypes#332674ClinicalTrials.gov
• Personalized Exercise Therapy and Self-management Support for Patients With Multimorbidity#343726ClinicalTrials.gov
• Renal Denervation in Patients With Chronic Heart Failure and Resynchronization Therapy#346839ClinicalTrials.gov
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure#353356ClinicalTrials.gov
• Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study#353389ClinicalTrials.gov
• Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)#366519ClinicalTrials.gov
• Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure#366525ClinicalTrials.gov
• Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals#366544ClinicalTrials.gov
• Transcatheter Tricuspid Valve Replacement Beyond Boundaries#68266HAL (France)
• Dapagliflozin for cardiorenal protection after intensive care unit discharge: a protocol for a randomised controlled trial evaluating dapagliflozin at ICU discharge for cardiorenal protection (DAPA-ICU)#121981HAL (France)
• Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Using Real-World Data: An Updated Systematic Review and Meta-Analysis#200321Figshare
• Table 4_Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway.xlsx#224168Figshare
• Table 2_Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway.xlsx#224172Figshare
• Table 3_Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway.xlsx#224173Figshare

Related topics